You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BioNTech SE

Showing 1 - 25 of 548
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Endometrial Cancer Trial (Pembrolizumab, GEN1046)

Not yet recruiting
  • Advanced Endometrial Cancer
  • (no location specified)
Sep 14, 2023

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Solid Tumor Trial in Tokyo (GEN1046)

Recruiting
  • Solid Tumor
  • GEN1046
  • Tokyo, Japan
  • +1 more
Jan 13, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Solid Tumor, Adult Trial (GEN1053)

Not yet recruiting
  • Solid Tumor, Adult
  • GEN1053
  • (no location specified)
Aug 11, 2022

Solid Tumor, Adult Trial in Chisinau, Madrid, Pamplona (GEN1056)

Recruiting
  • Solid Tumor, Adult
  • GEN1056
  • Chisinau, Moldova, Republic of
  • +2 more
Dec 9, 2022

Non-CNS Tumor Trial (biological, drug, radiation)

Not yet recruiting
  • Non-CNS Tumor
  • GEN1042
  • +2 more
  • (no location specified)
Aug 4, 2022

Advanced NSCLC Trial (BNT116, Cemiplimab)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jan 3, 2023

Carcinoma, Squamous Cell, Head and Neck Tumor, Cervical Tumor Trial in Southampton (BNT113)

Recruiting
  • Carcinoma, Squamous Cell
  • +3 more
  • Southampton, Hampshire, United Kingdom
    Univeristy Hospitals Southampton NHS Foundation Trust
May 17, 2022

Pancreatic Cancer, Tumors That Express CA19-9 Trial in United States (MVT-2163, MVT-5873)

Recruiting
  • Pancreatic Cancer
  • Tumors That Express CA19-9
  • Basking Ridge, New Jersey
  • +6 more
May 3, 2022

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (GEN1046, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • GEN1046
  • Pembrolizumab
  • Santa Rosa, California
  • +26 more
Jan 30, 2023

Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,

Recruiting
  • Malignant Solid Tumor
  • +5 more
  • GEN1042
  • +8 more
  • San Diego, California
  • +27 more
Dec 24, 2022

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Solid Tumors, NSCLC, Urothelial Carcinoma Trial in Worldwide (GEN1046, GEN1046 in combination with docetaxel (in a single

Recruiting
  • Solid Tumors
  • +6 more
  • GEN1046
  • +2 more
  • Phoenix, Arizona
  • +40 more
Jan 14, 2022

Monkeypox Trial (BNT166a, BNT166c)

Not yet recruiting
  • Monkeypox
  • BNT166a
  • BNT166c
  • (no location specified)
Aug 4, 2023

Malaria Trial in Tempe, Knoxville, San Antonio (BNT165b1, Placebo)

Recruiting
  • Malaria
  • BNT165b1
  • Placebo
  • Tempe, Arizona
  • +2 more
Jan 12, 2023

Malaria Trial (BNT165e, Placebo)

Not yet recruiting
  • Malaria
  • BNT165e
  • Placebo
  • (no location specified)
Sep 29, 2023

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Jan 18, 2023

Melanoma Trial in Germany (Lipo-MERIT)

Active, not recruiting
  • Melanoma
  • Lipo-MERIT
  • Frankfurt, Germany
  • +3 more
Jan 5, 2023

NSCLC Trial in Budapest, Gyongyos (BNT116, Cemiplimab, Docetaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • BNT116
  • +2 more
  • Baltimore, Maryland
  • +14 more
Dec 19, 2022

Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • BNT321 Dose Level 1
  • +3 more
  • (no location specified)
Sep 29, 2023

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Sep 8, 2022

Resected Stage II or Stage III Colorectal Cancer for Circulating

Recruiting
  • Colorectal Cancer Stage II
  • Colorectal Cancer Stage III
  • Regular blood sample collection for ctDNA assessment
  • California City, California
  • +66 more
Jan 6, 2023

Advanced Malignant Solid Tumor Trial in Huntersville (BNT314, Pembrolizumab)

Not yet recruiting
  • Advanced Malignant Solid Tumor
  • BNT314
  • Pembrolizumab
  • Huntersville, North Carolina
    Carolina BioOncology Institute, LLC
Nov 21, 2023

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2 (Omi XBB.1.5)
  • Dublin, California
  • +14 more
Aug 10, 2023